Stewart Fisher
2021
In 2021, Stewart Fisher earned a total compensation of $3.8M as Chief Scientific Officer at C4 Therapeutics, a 138% increase compared to previous year.
Compensation breakdown
| Bonus | $54,000 |
|---|---|
| Non-Equity Incentive Plan | $200,000 |
| Option Awards | $3,094,174 |
| Salary | $434,700 |
| Other | $6,000 |
| Total | $3,788,874 |
Fisher received $3.1M in option awards, accounting for 82% of the total pay in 2021.
Fisher also received $54K in bonus, $200K in non-equity incentive plan, $434.7K in salary and $6K in other compensation.
Rankings
In 2021, Stewart Fisher's compensation ranked 3,515th out of 12,415 executives tracked by ExecPay. In other words, Fisher earned more than 71.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,515 out of 12,415 | 72nd |
Division Manufacturing | 1,441 out of 5,508 | 74th |
Major group Chemicals And Allied Products | 583 out of 2,378 | 76th |
Industry group Drugs | 520 out of 2,099 | 75th |
Industry Biological Products, Except Diagnostic Substances | 136 out of 449 | 70th |
Source: SEC filing on April 29, 2022.
Fisher's colleagues
We found five more compensation records of executives who worked with Stewart Fisher at C4 Therapeutics in 2021.